XML Feed for RxPG News   Add RxPG News Headlines to My Yahoo!   Javascript Syndication for RxPG News

Research Health World General
 
  Home
 
 Latest Research
 Cancer
 Psychiatry
  Depression
  Neuropsychiatry
  Personality Disorders
  Bulimia
  Anxiety
  Substance Abuse
  Suicide
  CFS
  Psychoses
   Bipolar Disorder
   Schizophrenia
  Child Psychiatry
  Learning-Disabilities
  Psychology
  Forensic Psychiatry
  Mood Disorders
  Sleep Disorders
  Peri-Natal Psychiatry
  Psychotherapy
  Anorexia Nervosa
 Genetics
 Surgery
 Aging
 Ophthalmology
 Gynaecology
 Neurosciences
 Pharmacology
 Cardiology
 Obstetrics
 Infectious Diseases
 Respiratory Medicine
 Pathology
 Endocrinology
 Immunology
 Nephrology
 Gastroenterology
 Biotechnology
 Radiology
 Dermatology
 Microbiology
 Haematology
 Dental
 ENT
 Environment
 Embryology
 Orthopedics
 Metabolism
 Anaethesia
 Paediatrics
 Public Health
 Urology
 Musculoskeletal
 Clinical Trials
 Physiology
 Biochemistry
 Cytology
 Traumatology
 Rheumatology
 
 Medical News
 Health
 Opinion
 Healthcare
 Professionals
 Launch
 Awards & Prizes
 
 Careers
 Medical
 Nursing
 Dental
 
 Special Topics
 Euthanasia
 Ethics
 Evolution
 Odd Medical News
 Feature
 
 World News
 Tsunami
 Epidemics
 Climate
 Business
 
 India
Search

Last Updated: Nov 18, 2006 - 12:32:53 PM

Schizophrenia Channel
subscribe to Schizophrenia newsletter

Latest Research : Psychiatry : Psychoses : Schizophrenia

   DISCUSS   |   EMAIL   |   PRINT
Painkillers during pregnancy increase risk of schizophrenia by four times
Nov 2, 2004 - 3:17:00 PM, Reviewed by: Dr.



 
Children born to mothers who took analgesics in the second three months of pregnancy run a more than four-fold greater risk of developing schizophrenia, a new study from Denmark has found.

Published in the November issue of the British Journal of Psychiatry, the study set out to shed light on the hypothesis that prenatal exposure to analgesics may affect the development of the nervous system of the foetus, leading to an increased risk of schizophrenia in adulthood.

The researchers analysed data from the Copenhagen Perinatal Cohort, which consists of 9125 individuals delivered by 8949 pregnant women between October 1959 and December 1961. A total of 8400 infants survived the first month after birth.

Information on exposure to analgesics and psychiatric hospitalisation was available for 7999 people from the Perinatal Cohort. It was found that the prevalence of exposure to analgesics at any time during the first trimester was 0.9%; during the second trimester 1.8%; and during the third, 2.0%.

A total of 116 cases of schizophrenia were identified. For the first trimester, the risk was only significant for the third month, and was not significant for the third trimester. However, the incidence of schizophrenia in both males and females in the analgesic exposure group during the second trimester was more than four times higher than in the non-exposure group during that period.

The association was slightly stronger in females than males. Importantly, it was independent of maternal schizophrenia, which was the strongest risk factor for schizophrenia in this study.

Other known risk factors, such as parental history of schizophrenia, second-trimester viral infections, treatment with other drugs, pregnancy complications, parental social status and parental age were all taken into account. The link between prenatal exposure to analgesics and schizophrenia was found to be independent of all these risk factors.

The authors comment that during the second trimester of pregnancy a part of the brain called the cortical subplate reaches its peak of development. This may be a period when the immature foetal brain is particularly sensitive to a range of environmental influences.

It was previously found from data from the Copenhagen Perinatal Cohort that the risk of having malformed children was over twice as high in mothers who took analgesics during pregnancy. This discovery is of potential relevance to theories on causal factors in schizophrenia, as well.

A large number of physical defects, such as cleft palate, large or small distance between tear ducts and adherent earlobes have been linked to schizophrenia-spectrum disorders in a sample of the Copenhagen Perinatal Cohort.

The researchers also found that taking psychiatric medications during the second trimester was associated with intake of analgesics during the same period. Taking both these medications could be associated with increased levels of psychiatric problems and/or a tendency to consult a physician more often.

However, it would have required a larger cohort study and the collection of additional prenatal and perinatal data to disentangle effects of prenatal exposure to analgesic drugs from the effects of the somatic and psychosomatic conditions prompting their use.

The authors of the study caution that as only 6.9% of all the cohort members with schizophrenia had been exposed to analgesics in the second trimester, this research needs to be replicated before prenatal exposure to analgesics can be added to the list of demonstrated risk factors for schizophrenia.

Reference:
Holger J, Sorensen E L, Mortensen L, Reinisch J M and Mednick S A (2004) Association between prenatal exposure to analgesics and risk of schizophrenia. British Journal of Psychiatry, 185, 366-371.
 

-
 

 
Subscribe to Schizophrenia Newsletter
E-mail Address:

 



Related Schizophrenia News

Study aims to identify schizophrenics at risk for type 2 diabetes
Effects of ketamine mimic only some of the symptoms of schizophrenia
Association between famine and schizophrenia may yield clues about genetic basis
Neuropeptide S (NPS) may help in treating schizophrenia
Neuropeptide S (NPS) may help in treating schizophrenia
NMDA receptor hypofunction demonstrated in schizophrenia
Altered NRG1-erbB4 signaling may contribute to NMDA receptor hypofunction in schizophrenia
Transcription factor Elk-1's role in neurodegeneration and schizophrenia
Schizophrenia limits one's ability to perceive body language
Hospitalized schizophrenics are at a higher risk for developing medical/surgical complications


For any corrections of factual information, to contact the editors or to send any medical news or health news press releases, use feedback form

Top of Page

 

© Copyright 2004 onwards by RxPG Medical Solutions Private Limited
Contact Us